Pharma Focus Europe
ThermoFisher Scientific - Custom and Bulks

Novel Phoenix® Therapy Developed to Treat PTSD

Evren Technologies has developed a groundbreaking therapy called Phoenix® specifically designed for the treatment of Post-traumatic Stress Disorder (PTSD).

The Phoenix® therapy involves using earbud devices that deliver a gentle electrical stimulation to activate the vagus nerve, inducing a calming effect on the body and helping to alleviate the symptoms of PTSD.

With its discreet earbud design, the Phoenix® device enables transcutaneous auricular vagal nerve stimulation (taVNS) to be delivered effectively.

By incorporating transcutaneous auricular vagal nerve stimulation (taVNS) in a closed-loop system, the Phoenix earbud device offers personalized medicine that addresses the underlying autonomic imbalance associated with PTSD.

Recognizing its revolutionary potential, the Phoenix® therapy has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for the treatment of Post-traumatic Stress Disorder (PTSD).

PTSD affects a significant number of individuals, with approximately 7.5 million Americans seeking treatment for this condition annually. Furthermore, the rates of PTSD have significantly increased as a result of the COVID-19 pandemic.

magazine-slider-img
Get instant
access to our latest e-book
patheon - Mastering API production at every scaleLab Indonesia 20247th Pharma Packaging and Labelling Forum 2024Future Labs Live - 2024World Orphan Drug Congress 2024World Vaccine Congress Europe 2024Sartorius Webinar - Pave Your Weigh to Accurate Analytical ResultsEUROPEAN PHARMA OUTSOURCING SUMMIT 2024patheon - Revolutionizing PharmaWorld Vaccine Congress Europe 2024